Page last updated: 2024-10-23

benzyl isothiocyanate and Cancer of Ovary

benzyl isothiocyanate has been researched along with Cancer of Ovary in 3 studies

benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma

Research Excerpts

ExcerptRelevanceReference
"Advanced ovarian cancer (OC) is not curable by surgery alone and chemotherapy is essential for its treatment."1.33Benzyl isothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro. ( Brard, L; Dizon, DS; Kalkunte, S; Swamy, N, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamy, E1
Oey, D1
Eißmann, F1
Herz, C1
Münstedt, K1
Tinneberg, HR1
Mersch-Sundermann, V1
Kalkunte, S1
Swamy, N1
Dizon, DS1
Brard, L1
Pintão, AM1
Pais, MS1
Coley, H1
Kelland, LR1
Judson, IR1

Other Studies

3 other studies available for benzyl isothiocyanate and Cancer of Ovary

ArticleYear
Erucin and benzyl isothiocyanate suppress growth of late stage primary human ovarian carcinoma cells and telomerase activity in vitro.
    Phytotherapy research : PTR, 2013, Volume: 27, Issue:7

    Topics: Acetylcysteine; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Down-Regulation; Fema

2013
Benzyl isothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro.
    Journal of experimental therapeutics & oncology, 2006, Volume: 5, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; DNA Replication; Enzyme Activation;

2006
In vitro and in vivo antitumor activity of benzyl isothiocyanate: a natural product from Tropaeolum majus.
    Planta medica, 1995, Volume: 61, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line; Female; Humans; Isothiocyanates; Leukemia L1210; Lung Neo

1995